Trevena, Inc. Annual report pursuant to Section 13 and 15(d)

Accrued Expenses and Other Current Liabilities

12 Months Ended

Dec. 31, 2015

5. Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following:

	December 31,
	2015		2014
Compensation and benefits	$	2,599,565	$	1,628,102
Clinical trial expenses		401,029		846,199
Other research and development expenses		—		96,088
Other accrued expenses and other current liabilities		29,188		7,880

Total accrued expenses and other current liabilities	$	3,029,782	$	2,578,269